Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)
HKD 18.04
(0.33%)
HKD 18.04
(0.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 78.58 Billion CNY | 5.25% |
| 2022 | 74.66 Billion CNY | 12.93% |
| 2021 | 66.11 Billion CNY | 10.64% |
| 2020 | 59.76 Billion CNY | 5.04% |
| 2019 | 56.89 Billion CNY | 10.51% |
| 2018 | 51.48 Billion CNY | 81.82% |
| 2017 | 28.31 Billion CNY | 9.34% |
| 2016 | 25.89 Billion CNY | 63.18% |
| 2015 | 15.87 Billion CNY | 11.68% |
| 2014 | 14.21 Billion CNY | 16.01% |
| 2013 | 12.24 Billion CNY | 96.45% |
| 2012 | 6.23 Billion CNY | 28.53% |
| 2011 | 4.85 Billion CNY | 8.37% |
| 2010 | 4.47 Billion CNY | 6.02% |
| 2009 | 4.22 Billion CNY | 2.22% |
| 2008 | 4.13 Billion CNY | -33.45% |
| 2007 | 6.2 Billion CNY | 14.74% |
| 2006 | 5.4 Billion CNY | 6.11% |
| 2005 | 5.09 Billion CNY | -1.64% |
| 2004 | 5.18 Billion CNY | 10.11% |
| 2003 | 4.7 Billion CNY | 12.79% |
| 2002 | 4.17 Billion CNY | 12.87% |
| 2001 | 3.69 Billion CNY | 20.67% |
| 2000 | 3.06 Billion CNY | 1.25% |
| 1999 | 3.02 Billion CNY | 1.02% |
| 1998 | 2.99 Billion CNY | -0.11% |
| 1997 | 2.99 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 77.97 Billion CNY | -0.93% |
| 2024 Q3 | 79.25 Billion CNY | 1.65% |
| 2024 Q1 | 78.7 Billion CNY | 0.15% |
| 2023 Q4 | 78.58 Billion CNY | 5.69% |
| 2023 Q3 | 74.35 Billion CNY | 1.01% |
| 2023 Q1 | 73.65 Billion CNY | -1.35% |
| 2023 FY | 78.58 Billion CNY | 5.25% |
| 2023 Q2 | 73.6 Billion CNY | -0.07% |
| 2022 Q3 | 69.55 Billion CNY | 4.12% |
| 2022 FY | 74.66 Billion CNY | 12.93% |
| 2022 Q4 | 74.66 Billion CNY | 7.35% |
| 2022 Q2 | 66.8 Billion CNY | -0.36% |
| 2022 Q1 | 67.04 Billion CNY | 1.4% |
| 2021 Q4 | 66.11 Billion CNY | 2.37% |
| 2021 Q2 | 62.59 Billion CNY | -0.36% |
| 2021 FY | 66.11 Billion CNY | 10.64% |
| 2021 Q3 | 64.58 Billion CNY | 3.18% |
| 2021 Q1 | 62.82 Billion CNY | 5.13% |
| 2020 Q1 | 56.59 Billion CNY | -0.52% |
| 2020 Q3 | 58.04 Billion CNY | 5.34% |
| 2020 Q2 | 55.1 Billion CNY | -2.63% |
| 2020 FY | 59.76 Billion CNY | 5.04% |
| 2020 Q4 | 59.76 Billion CNY | 2.95% |
| 2019 Q2 | 53.35 Billion CNY | 3.0% |
| 2019 Q1 | 51.8 Billion CNY | 0.62% |
| 2019 FY | 56.89 Billion CNY | 10.51% |
| 2019 Q3 | 54.31 Billion CNY | 1.81% |
| 2019 Q4 | 56.89 Billion CNY | 4.74% |
| 2018 FY | 51.48 Billion CNY | 81.82% |
| 2018 Q4 | 51.48 Billion CNY | 3.81% |
| 2018 Q3 | 49.59 Billion CNY | 2.91% |
| 2018 Q2 | 48.19 Billion CNY | 67.12% |
| 2018 Q1 | 28.83 Billion CNY | 1.85% |
| 2017 Q3 | 27.02 Billion CNY | 1.21% |
| 2017 Q4 | 28.31 Billion CNY | 4.77% |
| 2017 FY | 28.31 Billion CNY | 9.34% |
| 2017 Q2 | 26.7 Billion CNY | 0.46% |
| 2017 Q1 | 26.57 Billion CNY | 2.64% |
| 2016 Q3 | 25.44 Billion CNY | 42.87% |
| 2016 Q1 | 16.95 Billion CNY | 6.83% |
| 2016 FY | 25.89 Billion CNY | 63.18% |
| 2016 Q4 | 25.89 Billion CNY | 1.76% |
| 2016 Q2 | 17.81 Billion CNY | 5.06% |
| 2015 Q2 | 16.49 Billion CNY | 10.58% |
| 2015 FY | 15.87 Billion CNY | 11.68% |
| 2015 Q4 | 15.87 Billion CNY | 0.31% |
| 2015 Q3 | 15.82 Billion CNY | -4.05% |
| 2015 Q1 | 14.91 Billion CNY | 4.94% |
| 2014 Q1 | 13.02 Billion CNY | 6.3% |
| 2014 Q4 | 14.21 Billion CNY | -0.27% |
| 2014 FY | 14.21 Billion CNY | 16.01% |
| 2014 Q3 | 14.24 Billion CNY | 3.26% |
| 2014 Q2 | 13.79 Billion CNY | 5.98% |
| 2013 Q3 | 11.92 Billion CNY | -0.09% |
| 2013 Q4 | 12.24 Billion CNY | 2.72% |
| 2013 FY | 12.24 Billion CNY | 96.45% |
| 2013 Q1 | 7.53 Billion CNY | 20.82% |
| 2013 Q2 | 11.93 Billion CNY | 58.44% |
| 2012 Q3 | 6.35 Billion CNY | 10.08% |
| 2012 Q4 | 6.23 Billion CNY | -1.81% |
| 2012 Q1 | 5.28 Billion CNY | 8.85% |
| 2012 FY | 6.23 Billion CNY | 28.53% |
| 2012 Q2 | 5.76 Billion CNY | 9.25% |
| 2011 Q3 | 4.83 Billion CNY | -0.85% |
| 2011 FY | 4.85 Billion CNY | 8.37% |
| 2011 Q4 | 4.85 Billion CNY | 0.39% |
| 2011 Q2 | 4.87 Billion CNY | 1.39% |
| 2011 Q1 | 4.8 Billion CNY | 7.37% |
| 2010 Q2 | 4.52 Billion CNY | 2.96% |
| 2010 Q3 | 4.53 Billion CNY | 0.23% |
| 2010 Q4 | 4.47 Billion CNY | -1.22% |
| 2010 Q1 | 4.39 Billion CNY | 4.01% |
| 2010 FY | 4.47 Billion CNY | 6.02% |
| 2009 FY | 4.22 Billion CNY | 2.22% |
| 2009 Q1 | 4.15 Billion CNY | 0.66% |
| 2009 Q2 | 4.19 Billion CNY | 0.96% |
| 2009 Q3 | 4.19 Billion CNY | -0.03% |
| 2009 Q4 | 4.22 Billion CNY | 0.61% |
| 2008 Q3 | 4.16 Billion CNY | -23.17% |
| 2008 Q2 | 5.41 Billion CNY | 1.7% |
| 2008 Q1 | 5.32 Billion CNY | -14.17% |
| 2008 Q4 | 4.13 Billion CNY | -0.76% |
| 2008 FY | 4.13 Billion CNY | -33.45% |
| 2007 Q1 | 5.88 Billion CNY | 8.84% |
| 2007 FY | 6.2 Billion CNY | 14.74% |
| 2007 Q4 | 6.2 Billion CNY | 0.93% |
| 2007 Q3 | 6.14 Billion CNY | 0.26% |
| 2007 Q2 | 6.13 Billion CNY | 4.19% |
| 2006 Q3 | 5.65 Billion CNY | 3.47% |
| 2006 Q2 | 5.46 Billion CNY | 0.3% |
| 2006 FY | 5.4 Billion CNY | 6.11% |
| 2006 Q1 | 5.44 Billion CNY | 6.9% |
| 2006 Q4 | 5.4 Billion CNY | -4.37% |
| 2005 Q4 | 5.09 Billion CNY | -5.18% |
| 2005 Q3 | 5.37 Billion CNY | 0.45% |
| 2005 Q2 | 5.35 Billion CNY | -2.97% |
| 2005 Q1 | 5.51 Billion CNY | 6.44% |
| 2005 FY | 5.09 Billion CNY | -1.64% |
| 2004 Q3 | 4.98 Billion CNY | 2.03% |
| 2004 Q4 | 5.18 Billion CNY | 3.92% |
| 2004 Q2 | 4.88 Billion CNY | 0.88% |
| 2004 FY | 5.18 Billion CNY | 10.11% |
| 2004 Q1 | 4.84 Billion CNY | 2.94% |
| 2003 Q2 | 4.46 Billion CNY | -0.64% |
| 2003 Q3 | 4.63 Billion CNY | 3.98% |
| 2003 Q4 | 4.7 Billion CNY | 1.49% |
| 2003 FY | 4.7 Billion CNY | 12.79% |
| 2003 Q1 | 4.48 Billion CNY | 7.57% |
| 2002 Q4 | 4.17 Billion CNY | 4.84% |
| 2002 Q1 | 3.8 Billion CNY | 2.81% |
| 2002 Q2 | 3.89 Billion CNY | 2.58% |
| 2002 Q3 | 3.98 Billion CNY | 2.09% |
| 2002 FY | 4.17 Billion CNY | 12.87% |
| 2001 Q2 | 3.79 Billion CNY | 0.0% |
| 2001 FY | 3.69 Billion CNY | 20.67% |
| 2001 Q4 | 3.69 Billion CNY | 0.0% |
| 2000 FY | 3.06 Billion CNY | 1.25% |
| 2000 Q4 | 3.06 Billion CNY | 0.0% |
| 1999 FY | 3.02 Billion CNY | 1.02% |
| 1998 FY | 2.99 Billion CNY | -0.11% |
| 1997 FY | 2.99 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -8560.045% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | -249.037% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -6005.31% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -3650.967% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -16336.746% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | -2618.642% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | -2679.319% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -4449.603% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -9211.65% |
| SSY Group Limited | 11.96 Billion HKD | -556.733% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -5559.037% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | -2153.805% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 71.075% |